OPTOMED.HEOPTOMED.HEHEL
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P38
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-8.44%
Q3 202525.79%
Q2 20253.13%
Q1 2025-35.98%
Q4 2024203.25%
Q3 2024-66.91%
Q2 2024112.35%
Q1 2024-13.80%
Q4 2023-20.73%
Q3 202334.27%
Q2 20230.85%
Q1 20235.82%
Q4 2022-4.69%
Q3 2022-6.89%
Q2 202211.85%
Q1 2022-50.55%
Q4 2021107.13%
Q3 2021-9.60%
Q2 2021-2.02%
Q1 2021-71.20%
Q4 202074.06%
Q3 2020-15.59%
Q2 2020-8.25%
Q1 2020-27.20%
Q4 201965.43%
Q3 2019-12.77%
Q2 20194.77%
Q1 2019-25.41%
Q4 201888.38%
Q3 20180.00%